Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The Significance of Autoantibodies in Juvenile Dermatomyositis.

BioMed research international - 1 Jan 2021

Kwiatkowska Dominika, Reich Adam

Abstract excerpt

Juvenile dermatomyositis is a chronic and rare autoimmune disorder classified into the spectrum of idiopathic inflammatory myopathies. Although this entity is mainly characterized by the presence of pathognomonic cutaneous lesions and proximal muscle weakness, the clinical manifestation can be highly heterogeneous; thus, diagnosis might be challenging. Current treatment recommendations for juvenile...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Signal Recognition Particle
Share to Amino Acyl-tRNA Synthetases
Share to Antibody Specificity

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Autoantigens

Share to Dermatomyositis

Share to Hydroxymethylglutaryl CoA Reductases

Share to Interferon-Induced Helicase, IFIH1

Share to Small Ubiquitin-Related Modifier Proteins

Source

Open in PubMed Open full text

Identifiers

PMID: 34840975
DOI: 10.1155/2021/5513544
PMCID: PMC8626176

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The Significance of Autoantibodies in Juvenile Dermatomyositis.PMID 34840975Read ↗

Juvenile dermatomyositis: immunopathogenesis, role of myositis-specific autoantibodies, and review of rituximab use.Semantic proximity Read ↗

Juvenile idiopathic inflammatory myositis: an update on pathophysiology and clinical care.Semantic proximity Read ↗

Myositis-specific autoantibodies and their associated phenotypes in juvenile dermatomyositis: data from a German cohort.Semantic proximity Read ↗

Immunopathogenesis of juvenile dermatomyositis.Semantic proximity Read ↗

Update on juvenile dermatomyositis: new advances in understanding its etiopathogenesis.Semantic proximity Read ↗

[The analysis of clinical phenotypes and autoantibodies in juvenile dermatomyositis].Semantic proximity Read ↗

The juvenile idiopathic inflammatory myopathies: pathogenesis, clinical and autoantibody phenotypes, and outcomes.Semantic proximity Read ↗

Antibodies in juvenile-onset myositis.Semantic proximity Read ↗

Clinical significance of autoantibodies in dermatomyositis and systemic sclerosis.Semantic proximity Read ↗

Myositis in children.Semantic proximity Read ↗

The clinical phenotypes of the juvenile idiopathic inflammatory myopathies.Semantic proximity Read ↗

Dermatomyositis and polymyositisSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.